Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfizer discontinues development of filibuvir drug
The drug, which is in mid-stage clinical testing, is facing competition from new hepatitis C treatments developed by Gilead Sciences (GILD) and AbbVie (ABBV). Pfizer spokeswoman Victoria Davis
The drug, which is in mid-stage clinical testing, is facing competition from new hepatitis C treatments developed by Gilead Sciences (GILD) and AbbVie (ABBV). Pfizer spokeswoman Victoria Davis
In 2012, the three organizations have partnered to combine Novavax’s vaccine technology, ICGEB’s malaria vaccine research expertise and CPLB manufacturing capability. India’s Department of Biotechnology Vaccine Grand Challenge
The policy has invited pharmaceutical companies in Karnataka to set up their plants in other parts of the state, instead of focusing only on Bangalore city. The policy
RI-002, a specialty plasma-derived, polyclonal intravenous immune globulin, contains naturally occurring polyclonal antibodies (eg. streptococcus pneumoniae, H. influenza type B, CMV, measles, tetanus etc) as well as high
Laquinimod, which has crossed the blood brain barrier to potentially have a direct effect on resident CNS inflammation and neurodegeneration in animal models, is a CNS-active immunomodulator exhibiting
AOD said the launch of the solution is part of the company’s commitment to deliver the most complete and seamless software solution in the long term care industry.
The PEGylated Fc-free anti-TNF medication is indicated for adult rheumatoid arthritis patients who showed poor response to conservative treatment. TNF-alpha factor, for which Cimzia has high affinity, plays
According to the study data, the addition of ranolazine to background antianginal therapy demonstrated reduced angina frequency in chronic angina patients with type 2 diabetes as compared to
Baycare Health Partners and Baystate Health have formed Pioneer Valley Health Information Exchange (PVIX), which will rely on HealthShare to provide a "one patient, one record" view across
According to DSMB, the pre planned interim analysis of efficacy and safety indicates that the study may not reach the significant difference in progression free survival, the primary